In the past 10 years, he has been focusing on the diagnosis and treatment of gynecological vulvar diseases, especially in the diagnosis and treatment of various types of proliferative, atrophic, mossy and mixed vulvar leukoplakia. The treatment level is leading in China, and the treatment efficiency of some cases has reached the international advanced level. In the diversification of gynecological vulvar diseases, I have accumulated a lot of experience and formed my own style. He is one of the technical founders of "Eukaryotic cell activation immune culture technology". He has successively undertaken 5 projects of the National Natural Science Foundation and 1 project of the Ministry of Health, and dozens of articles have been included in SCI and published in national core journals. Deputy editor-in-chief of Journal of Traditional Chinese Medicine for Vulvar Leukoplakia, Medicine and Clinic of Vulvar Leukoplakia, editorial board member of several medical magazines, and author of Four Seasons Talk on Women's Health Care.